Published: February 07, 2011
RemedyMD Announces New Hematopoietic Stem Cell Transplant (HSCT) Complete Research and CIBMTR Reporting Product, ComprehensiveBMT
SALT LAKE CITY - (BUSINESS WIRE) - RemedyMD
has identified the need within the HSCT
community to build software that can aggregate, link, harmonize, and
analyze data from patients and donors and then report data as necessary
to the CIBMTR.
Today, the company has announced its new product, which solves these
challenges and many others, calling it ComprehensiveBMT.
This new product solves key challenges of hematopoietic stem cell
transplant research such as
-
Electronically reporting essential and comprehensive data to the
NMDP/CIBMTR
-
Linking together HSCT data contained in myriad spreadsheets or
databases
-
'Harmonizing' that data with an AGNIS-approved ontology so it's
consistent and research-ready
-
Setting up and managing studies and experiments as well as
patient/donor information, and
-
Having robust tools and applications to mine, query, and report on
that data
ComprehensiveBMT includes a complete HSCT Registry linking together data
from many disparate sources such as EHR clinical data, research
databases and spreadsheets, gene arrays, imaging data, patient and donor
self-reported data, and many others. By linking together all of these
data sources and then 'normalizing' that data HSCT researchers gain a
360° view of every patient or subject to recognize patterns or identify
trends that were not visible without a comprehensive registry and
sophisticated data analysis tools.
Matthew Gress, ComprehensiveBMT product manager, adds, "RemedyMD worked
closely with the CIBMTR when building the forms included with the
product, and we're very happy with the end result. Users get the benefit
of submitting forms electronically, with a built-in ontology that works
with AGNIS, plus all of the Mosaic Meta-Registry data infrastructure
and tools for collecting and normalizing data, mining that data, and
even managing studies and experiments."
"Building ComprehensiveBMT was an excellent way to affirm the robustness
of our tool set. We were able to build out this BMT Registry including
all the essential forms and all the approved comprehensive level forms
is less than three weeks," said Jim Hyde, President and COO of RemedyMD.
"We are committed to using our technology platform to stay ahead of the
new comprehensive forms as they are released."
RemedyMD will be at Booth 17 at the 2011 Tandem Meetings in Honolulu, HI
beginning Feb. 17 through Feb. 21, with CEO and Founder Gary D. Kennedy
(former ORACLE President, USA) meeting with several key constituents in
the HSCT community.
ComprehensiveBMT will also be demonstrated in two upcoming free online
seminars hosted by RemedyMD, titled "ComprehensiveBMT-Redefining HSCT
Data Aggregation, Analysis, and Reporting" to be held Wed.,
March 2 at 2 PM (EST) or April
14 at Noon (EST). For more information or to register visit http://www.remedymd.com/RemedyMD-Live-Webinars.php.
Sample organizations using RemedyMD registries include Wisconsin's Blood
Research Institute, Children's National Medical Center, Oklahoma Medical
Research Foundation (OMRF), and several others.
About RemedyMD
RemedyMD's registry software enables basic
scientists, clinical
researchers, outcomes
researchers, and translational
researchers to aggregate and harmonize data from widely disparate
sources and then use our tools and applications to identify patterns
that result in accelerated discoveries. We offer tools
to collect, host, manage, and query
data regardless of source; conduct
experiments; manage
studies and biospecimen;
and for helping you build
your own registries. For more information visit: www.RemedyMD.com.
RemedyMD
Don Holm, 801-733-3373
dholm@remedymd.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News
Search News
